Department of Pathology, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; McGowan Institute for Regenerative Medicine, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; Pittsburgh Liver Research Center, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Department of Pathology, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; Pittsburgh Liver Research Center, University of Pittsburgh School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Am J Pathol. 2022 Sep;192(9):1259-1281. doi: 10.1016/j.ajpath.2022.06.002. Epub 2022 Jun 16.
Nonalcoholic fatty liver disease (NAFLD) is an epidemic affecting 30% of the US population. It is characterized by insulin resistance, and by defective lipid metabolism and mitochondrial dysfunction in the liver. SLC25A34 is a major repressive target of miR-122, a miR that has a central role in NAFLD and liver cancer. However, little is known about the function of SLC25A34. To investigate SLC25A34 in vitro, mitochondrial respiration and bioenergetics were examined using hepatocytes depleted of Slc25a34 or overexpressing Slc25a34. To test the function of SLC25A34 in vivo, a hepatocyte-specific knockout mouse was generated, and loss of SLC25A34 was assessed in mice maintained on a chow diet and a fast-food diet (FFD), a model for NAFLD. Hepatocytes depleted of Slc25a34 displayed increased mitochondrial biogenesis, lipid synthesis, and ADP/ATP ratio; Slc25a34 overexpression had the opposite effect. In the knockout model on chow diet, SLC25A34 loss modestly affected liver function (altered glucose metabolism was the most pronounced defect). RNA-sequencing revealed changes in metabolic processes, especially fatty acid metabolism. After 2 months on FFD, knockouts had a more severe phenotype, with increased lipid content and impaired glucose tolerance, which was attenuated after longer FFD feeding (6 months). This work thus presents a novel model for studying SLC25A34 in vivo in which SLC25A34 plays a role in mitochondrial respiration and bioenergetics during NAFLD.
非酒精性脂肪性肝病 (NAFLD) 是一种影响美国 30%人口的流行疾病。其特征为胰岛素抵抗,以及肝脏中脂质代谢和线粒体功能缺陷。SLC25A34 是 miR-122 的主要抑制靶标,miR-122 在 NAFLD 和肝癌中具有核心作用。然而,对于 SLC25A34 的功能知之甚少。为了在体外研究 SLC25A34,使用耗尽 Slc25a34 或过表达 Slc25a34 的肝细胞来检查线粒体呼吸和生物能量。为了测试 SLC25A34 在体内的功能,生成了一种肝细胞特异性敲除小鼠,并在维持在常规饮食和快餐饮食 (FFD) 的小鼠中评估 SLC25A34 的缺失,FFD 是 NAFLD 的模型。耗尽 Slc25a34 的肝细胞显示出增加的线粒体生物发生、脂质合成和 ADP/ATP 比;Slc25a34 的过表达则具有相反的效果。在常规饮食的敲除模型中,SLC25A34 的缺失轻微影响肝功能(改变葡萄糖代谢是最明显的缺陷)。RNA 测序揭示了代谢过程的变化,特别是脂肪酸代谢。在 FFD 上 2 个月后,敲除小鼠表现出更严重的表型,脂质含量增加,葡萄糖耐量受损,在更长时间的 FFD 喂养后(6 个月)得到缓解。因此,这项工作提出了一种新的体内研究 SLC25A34 的模型,其中 SLC25A34 在 NAFLD 期间在线粒体呼吸和生物能量中发挥作用。